ベータ・アドレノ受容体アゴニストと阻害性呼吸道疾患

Computational Study of the Dimerization of the Parathyroid Hormone.

The journal of physical chemistry. B·2025

Nanoscopically Confined 1,4-Polybutadiene Melts: Exploring Confinement by Alumina Nanorod and Nanopore Systems.

The journal of physical chemistry. B·2024

Phase transitions in the classical simulability of open quantum systems.

Scientific reports·2023

Structure and dynamics of a 1,4-polybutadiene melt in an alumina nanopore: A molecular dynamics simulation.

The Journal of chemical physics·2022

Role of torsional potential in chain conformation, thermodynamics, and glass formation of simulated polybutadiene melts.

The Journal of chemical physics·2022

Otherwise identical particles with differing, fixed speeds demix under time-reversible dynamics.

Physical review. E·2020

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Mutation-Induced Pocket Deactivation: How Ser353/Pro245 Alters KCa2.2 vs. KCa3.1 Ligand Selectivity.

Archiv der Pharmazie·2026

A small molecule reduces both parkinsonism and l-dopa-induced dyskinesia in animal models of Parkinson's disease.

Science translational medicine·2026

Efficacy of DPP-4 Inhibitors on Seated and Ambulatory Blood Pressure in Type 2 Diabetes Mellitus.

Diabetes, obesity & metabolism·2026

Ameliorative Effects of Spirulina platensis Protein Hydrolysate on Oxidative Stress and Dyslipidemia in Model Animal.

Foods (Basel, Switzerland)·2026

Comparison of essential drug lists: concordance, differences, and the need for core lists in times of crisis.

Naunyn-Schmiedeberg's archives of pharmacology·2026

Buprenorphine-Naloxone vs Extended-Release Naltrexone Following Opioid Withdrawal Treatment.

JAMA network open·2026

関連する実験動画

ベータ・アドレノ受容体アゴニストと阻害性呼吸道疾患

関連する概念動画

Computational Study of the Dimerization of the Parathyroid Hormone.

Nanoscopically Confined 1,4-Polybutadiene Melts: Exploring Confinement by Alumina Nanorod and Nanopore Systems.

Phase transitions in the classical simulability of open quantum systems.

Structure and dynamics of a 1,4-polybutadiene melt in an alumina nanopore: A molecular dynamics simulation.

Role of torsional potential in chain conformation, thermodynamics, and glass formation of simulated polybutadiene melts.

Otherwise identical particles with differing, fixed speeds demix under time-reversible dynamics.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Mutation-Induced Pocket Deactivation: How Ser353/Pro245 Alters K<sub>Ca</sub>2.2 vs. K<sub>Ca</sub>3.1 Ligand Selectivity.

A small molecule reduces both parkinsonism and l-dopa-induced dyskinesia in animal models of Parkinson's disease.

Efficacy of DPP-4 Inhibitors on Seated and Ambulatory Blood Pressure in Type 2 Diabetes Mellitus.

Ameliorative Effects of <i>Spirulina platensis</i> Protein Hydrolysate on Oxidative Stress and Dyslipidemia in Model Animal.

Comparison of essential drug lists: concordance, differences, and the need for core lists in times of crisis.

Buprenorphine-Naloxone vs Extended-Release Naltrexone Following Opioid Withdrawal Treatment.

関連する実験動画

ベータ・アドレノ受容体アゴニストと阻害性呼吸道疾患

関連する概念動画

関連記事